Next Article in Journal
An Evolutionarily Young Polar Bear (Ursus maritimus) Endogenous Retrovirus Identified from Next Generation Sequence Data
Next Article in Special Issue
From Immunodeficiency to Humanization: The Contribution of Mouse Models to Explore HTLV-1 Leukemogenesis
Previous Article in Journal
Coxsackievirus B4 Can Infect Human Peripheral Blood-Derived Macrophages
Previous Article in Special Issue
Human T-Lymphotropic Virus Type I (HTLV-1) Infection among Iranian Blood Donors: First Case-Control Study on the Risk Factors

Recent Advances in BLV Research

Molecular and Cellular Epigenetics (GIGA) and Molecular Biology (Gembloux Agro-Bio Tech), University of Liège (ULg), Liège 4000, Belgium
Instituto de Virología, Centro de Investigaciones en Ciencias Veterinarias y Agronómicas, INTA, Castelar C.C. 1712, Argentina
Department of Pathology, National Veterinary Research Institute, Pulawy 24-110, Poland
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Louis Mansky
Viruses 2015, 7(11), 6080-6088;
Received: 28 September 2015 / Accepted: 19 November 2015 / Published: 24 November 2015
(This article belongs to the Special Issue Recent Advances in HTLV Research 2015)
Different animal models have been proposed to investigate the mechanisms of Human T-lymphotropic Virus (HTLV)-induced pathogenesis: rats, transgenic and NOD-SCID/γcnull (NOG) mice, rabbits, squirrel monkeys, baboons and macaques. These systems indeed provide useful information but have intrinsic limitations such as lack of disease relevance, species specificity or inadequate immune response. Another strategy based on a comparative virology approach is to characterize a related pathogen and to speculate on possible shared mechanisms. In this perspective, bovine leukemia virus (BLV), another member of the deltaretrovirus genus, is evolutionary related to HTLV-1. BLV induces lymphoproliferative disorders in ruminants providing useful information on the mechanisms of viral persistence, genetic determinants of pathogenesis and potential novel therapies. View Full-Text
Keywords: BLV; HTLV-1; Tax; microRNA; vaccine; HDAC BLV; HTLV-1; Tax; microRNA; vaccine; HDAC
Show Figures

Figure 1

MDPI and ACS Style

Barez, P.-Y.; De Brogniez, A.; Carpentier, A.; Gazon, H.; Gillet, N.; Gutiérrez, G.; Hamaidia, M.; Jacques, J.-R.; Perike, S.; Neelature Sriramareddy, S.; Renotte, N.; Staumont, B.; Reichert, M.; Trono, K.; Willems, L. Recent Advances in BLV Research. Viruses 2015, 7, 6080-6088.

AMA Style

Barez P-Y, De Brogniez A, Carpentier A, Gazon H, Gillet N, Gutiérrez G, Hamaidia M, Jacques J-R, Perike S, Neelature Sriramareddy S, Renotte N, Staumont B, Reichert M, Trono K, Willems L. Recent Advances in BLV Research. Viruses. 2015; 7(11):6080-6088.

Chicago/Turabian Style

Barez, Pierre-Yves, Alix De Brogniez, Alexandre Carpentier, Hélène Gazon, Nicolas Gillet, Gerónimo Gutiérrez, Malik Hamaidia, Jean-Rock Jacques, Srikanth Perike, Sathya Neelature Sriramareddy, Nathalie Renotte, Bernard Staumont, Michal Reichert, Karina Trono, and Luc Willems. 2015. "Recent Advances in BLV Research" Viruses 7, no. 11: 6080-6088.

Find Other Styles

Article Access Map by Country/Region

Back to TopTop